| Quincey Buechler, PA | |
|
2900 12th Ave N Ste 503e, Billings, MT 59101-7502 | |
| (406) 237-5780 | |
| (406) 237-5785 |
| Full Name | Quincey Buechler |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 4 Years |
| Location | 2900 12th Ave N Ste 503e, Billings, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770180036 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 91038 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Vincent Healthcare | Billings, MT | Hospital |
| Central Montana Medical Center | Lewistown, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scl Health Montana | 3476457714 | 43 |
News Archive
Genentech, Inc., a member of the Roche Group, and Biogen Idec today announced 24-week results from a phase II study of ocrelizumab in patients with relapsing-remitting multiple sclerosis (RRMS), the most common form of the disease. Ocrelizumab demonstrated a significant reduction in disease activity as measured by brain lesions and relapse rate.
Genzyme Corporation announced today that it has received a complete response letter from the FDA regarding its application to market Lumizyme™ (alglucosidase alfa) for the treatment of Pompe disease. In its letter, the agency stated that satisfactory resolution of deficiencies related to the Allston Landing manufacturing plant are required before the Lumizyme application can be approved.
Congressional Republicans said on Sunday they plan a full-scale assault against President Barack Obama's healthcare overhaul next year but acknowledged it could take until after the 2012 presidential election to repeal it. Representative Paul Ryan, expected to become chairman of the House Budget Committee chairman, said his fellow Republicans will try to deny funding for implementation of the healthcare legislation and hold hearings to point out its shortcomings when the new Congress convenes in January.
More than a decade of targeted Muscular Dystrophy Association-funded research, made possible as a result of generous public support of the MDA Labor Day Telethon and thousands of grass-roots special events, has today culminated in MDA providing financial assistance for the start of the first Phase 2 placebo-controlled, multiple dose efficacy, safety, tolerability and pharmacokinetics clinical trial of an exon-51 skipping drug, eteplirsen, as a potential therapy for Duchenne muscular dystrophy.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Quincey Buechler, PA 2900 12th Ave N Ste 503e, Billings, MT 59101-7502 Ph: (406) 237-5780 | Quincey Buechler, PA 2900 12th Ave N Ste 503e, Billings, MT 59101-7502 Ph: (406) 237-5780 |
News Archive
Genentech, Inc., a member of the Roche Group, and Biogen Idec today announced 24-week results from a phase II study of ocrelizumab in patients with relapsing-remitting multiple sclerosis (RRMS), the most common form of the disease. Ocrelizumab demonstrated a significant reduction in disease activity as measured by brain lesions and relapse rate.
Genzyme Corporation announced today that it has received a complete response letter from the FDA regarding its application to market Lumizyme™ (alglucosidase alfa) for the treatment of Pompe disease. In its letter, the agency stated that satisfactory resolution of deficiencies related to the Allston Landing manufacturing plant are required before the Lumizyme application can be approved.
Congressional Republicans said on Sunday they plan a full-scale assault against President Barack Obama's healthcare overhaul next year but acknowledged it could take until after the 2012 presidential election to repeal it. Representative Paul Ryan, expected to become chairman of the House Budget Committee chairman, said his fellow Republicans will try to deny funding for implementation of the healthcare legislation and hold hearings to point out its shortcomings when the new Congress convenes in January.
More than a decade of targeted Muscular Dystrophy Association-funded research, made possible as a result of generous public support of the MDA Labor Day Telethon and thousands of grass-roots special events, has today culminated in MDA providing financial assistance for the start of the first Phase 2 placebo-controlled, multiple dose efficacy, safety, tolerability and pharmacokinetics clinical trial of an exon-51 skipping drug, eteplirsen, as a potential therapy for Duchenne muscular dystrophy.
› Verified 8 days ago
Kirk Kenfield, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Alexander Ramsey, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Kaitlyn Steele, PA-C Physician Assistant Medicare: May Accept Medicare Assignments Practice Location: 1611 Zimmerman Trl, Billings, MT 59102 Phone: 406-248-3607 | |
Trenay Hart, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 406-237-4141 Fax: 406-237-4126 | |
Melanie Schmitz, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Jamaica Rachel Moore, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 801 North 29th Street, Billings Clinic, Billings, MT 59101 Phone: 406-238-2410 | |
Kortney Ann Gaughan, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 2900 12th Ave N Ste 160w, Billings, MT 59101 Phone: 406-237-4580 |